Canada markets open in 6 hours 41 minutes

Celon Pharma S.A. (8RP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.36000.0000 (0.00%)
At close: 08:24AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 180.00M
Enterprise Value 159.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.50
Price/Book (mrq)1.66
Enterprise Value/Revenue 0.97
Enterprise Value/EBITDA 4.87

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 38.56%
S&P500 52-Week Change 323.10%
52 Week High 33.9000
52 Week Low 33.0300
50-Day Moving Average 33.4094
200-Day Moving Average 33.4053

Share Statistics

Avg Vol (3 month) 311
Avg Vol (10 day) 3N/A
Shares Outstanding 551.06M
Implied Shares Outstanding 653.37M
Float 821.02M
% Held by Insiders 158.81%
% Held by Institutions 111.03%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.02
Forward Annual Dividend Yield 40.61%
Trailing Annual Dividend Rate 30.09
Trailing Annual Dividend Yield 32.68%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 29, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in PLN.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -11.72%
Operating Margin (ttm)-20.69%

Management Effectiveness

Return on Assets (ttm)-2.59%
Return on Equity (ttm)-5.28%

Income Statement

Revenue (ttm)214.47M
Revenue Per Share (ttm)4.20
Quarterly Revenue Growth (yoy)7.70%
Gross Profit (ttm)N/A
EBITDA 2.85M
Net Income Avi to Common (ttm)-25.14M
Diluted EPS (ttm)-0.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)101.95M
Total Cash Per Share (mrq)2
Total Debt (mrq)16.61M
Total Debt/Equity (mrq)3.61%
Current Ratio (mrq)2.27
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)6.76M
Levered Free Cash Flow (ttm)-18.82M